SoM Magnify

Subscribe to Magnify Magazine

Adapt and Innovate

November 13, 2020
By Dave Hart

This article first appeared in the DukeMed Alumni News Fall 2020 issue .

Last spring, when Prince Boadi accepted an offer to attend Duke University School of Medicine starting in the fall of 2020, he knew the experience—leaving his family and friends in Chicago, learning his way around Durham, meeting new people, and taking on the rigors of medical school—would be different from...Read Full Story

Years in the Making: Duke Human Vaccine Institute researchers attack COVID-19

When the novel coronavirus began to spread across China, researchers at the Duke Human Vaccine Institute (DHVI) sprang into action and they haven’t slowed down since. They are collaborating with each other and with other institutions to unlock the secrets of the virus that causes COVID-19 and to...Read Full Story

Three doctors involved with outpatient trials pose on Duke campus

Clinical Researchers Seek Ways to Lessen the Severity of COVID-19

New studies are underway at Duke to test treatments that could help people with COVID-19 recover faster and avoid being hospitalized.

“The goal of interventional outpatient studies is to see if we can prevent people from developing more severe COVID disease requiring hospitalization,”...Read Full Story

The Right Environment

New faculty recruit Opeyemi Olabisi is on a mission to revolutionize the prevention and treatment of kidney disease

Opeyemi Olabisi , MD, PhD, learned to ride a bicycle when he was 12 years old. He was living in Nigeria in a city called Ilorin, and a friend’s older brother, Yemi,...Read Full Story

Prepping for a Pandemic: Duke’s Long History of RNA-based Vaccine Development

As researchers around the world race to build a vaccine that can protect people from COVID-19, many of the frontrunners entering the final stretch—including those developed by biotechnology companies Moderna and BioNtech—are RNA-based vaccines.

RNA is the molecule that serves as a...Read Full Story

Pages